GlassScriptPhysician profile
Anandraj Mattai
NPI 1407070881
$2,362.70
in general payments reported to CMS, 2019-2025
20 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $1,126 · 2021: $183 · 2022: $182 · 2023: $210 · 2024: $90.30 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,062.45 | 2020-2023 | Spravato |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $175.00 | 2019 | |
| Epi Health, LLC | $109.25 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $107.82 | 2024-2025 | |
| Neuronetics, INC. | $107.40 | 2020-2023 | Neurostar Tms Therapy System |
| Ucb, INC. | $100.02 | 2024-2025 | Bimzelx |
| Axsome Therapeutics, INC. | $83.52 | 2022-2025 | Auvelity |
| Dermavant Sciences, INC. | $79.62 | 2023 | Vtama |
| Mayne Pharma Commercial LLC | $78.10 | 2019 | |
| Sunovion Pharmaceuticals INC. | $74.36 | 2021-2022 | |
| Incyte Corporation | $63.09 | 2021-2025 | Opzelura |
| Lundbeck LLC | $55.85 | 2019-2022 | |
| Amgen INC. | $50.21 | 2020-2022 | |
| Leo Pharma INC. | $49.92 | 2022 | |
| Abbvie INC. | $39.94 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $33.99 | 2020-2025 | Clear & Brilliant |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.48 | 2019-2020 | |
| Celgene Corporation | $23.88 | 2019 | |
| Dermira, INC. | $20.33 | 2020 | |
| Adlon Therapeutics L.P. | $18.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anandraj Mattai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.